Canada Pension Plan Investment Board’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
Other funds holding LYEL
AVM
GP
FCMI
OPL
VCM
DC
AC
FCMV
Canada Pension Plan Investment Board's LYEL Position: Q1 2026 in Review
Canada Pension Plan Investment Board reduced its Lyell Immunopharma (LYEL) stake by 8.4% in Q1 2026, selling an estimated $63.1K and leaving 29,411 shares worth $590K. The position accounts for ﹤0.01% of the portfolio, ranked #1186.
Canada Pension Plan Investment Board first reported a position in LYEL in Q2 2021 and has held it in 20 quarters since. The position peaked at $9.55M in Q2 2021. 74 funds tracked by Wall St. Rank hold LYEL as of Q1 2026.
- Canada Pension Plan Investment Board held 29,411 shares of Lyell Immunopharma worth $590K as of Q1 2026.
- Canada Pension Plan Investment Board sold 2,700 Lyell Immunopharma shares in Q1 2026, an estimated $63.1K.
- Lyell Immunopharma made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1186 holding.
- Canada Pension Plan Investment Board first reported a position in Lyell Immunopharma in Q2 2021 and has held it in 20 quarters since.
- Canada Pension Plan Investment Board's Lyell Immunopharma position peaked at $9.55M in Q2 2021.
- 74 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.